PetIQ Inc (PETQ)
17.04
+0.20
(+1.19%)
USD |
NASDAQ |
May 03, 16:00
17.02
-0.02
(-0.09%)
After-Hours: 20:00
PetIQ Profit Margin (Quarterly): -7.95% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -7.95% |
September 30, 2023 | 0.16% |
June 30, 2023 | 3.01% |
March 31, 2023 | 3.34% |
December 31, 2022 | -3.71% |
September 30, 2022 | -23.43% |
June 30, 2022 | 1.84% |
March 31, 2022 | 1.14% |
December 31, 2021 | -7.18% |
September 30, 2021 | -3.75% |
June 30, 2021 | 1.49% |
March 31, 2021 | 0.80% |
December 31, 2020 | -5.37% |
September 30, 2020 | -43.34% |
June 30, 2020 | -0.55% |
March 31, 2020 | -1.13% |
Date | Value |
---|---|
December 31, 2019 | -7.12% |
September 30, 2019 | -3.17% |
June 30, 2019 | 1.73% |
March 31, 2019 | 1.09% |
December 31, 2018 | -3.13% |
September 30, 2018 | 1.69% |
June 30, 2018 | 1.46% |
March 31, 2018 | -1.76% |
December 31, 2017 | -6.29% |
September 30, 2017 | -0.37% |
June 30, 2017 | 0.00% |
March 31, 2017 | 0.00% |
December 31, 2016 | 0.00% |
September 30, 2016 | 0.00% |
June 30, 2016 | 0.97% |
March 31, 2016 | -0.58% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-43.34%
Minimum
Sep 2020
3.34%
Maximum
Mar 2023
-4.91%
Average
-1.13%
Median
Mar 2020
Profit Margin (Quarterly) Benchmarks
Dynavax Technologies Corp | 0.39% |
Pacira BioSciences Inc | 13.72% |
Supernus Pharmaceuticals Inc | 0.72% |
Esperion Therapeutics Inc | -174.7% |
Deciphera Pharmaceuticals Inc | -97.71% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 0.94% |
Return on Assets | 0.25% |
Return on Invested Capital | 0.32% |
Gross Profit Margin (Quarterly) | 20.00% |
Operating Margin (Quarterly) | 0.57% |
Return on Net Operating Assets | 0.28% |